Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagnik Chatterjee

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 23, 2017
Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition AssayRavindranath Reddy Gilibili, Sagnik Chatterjee, Pravin Bagul, et al.
Journal of Pharmaceutical Sciences|March 22, 2014
Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate dispositionTom De Bruyn, Wouter Sempels, Jan Snoeys, et al.
Developmental Medicine and Child Neurology|August 15, 2025
Neonatal hypoglycaemic brain injury, a common cause of early-childhood epilepsy in India: A prospective longitudinal study on aetiologies and outcomesChitra Gupta, Bhuvandeep Narang, S G Thenral, et al.
Brain Communications|December 11, 2023
Early-infantile developmental and epileptic encephalopathy: the aetiologies, phenotypic differences and outcomes-a prospective observational studyPooja Agarwala, Bhuvandeep Narang, Thenral S Geetha, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2022
Repression of Organic Anion Transporting Polypeptide (OATP) 1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Downregulation in Cynomolgus Monkeys Treated with Chenodeoxycholic AcidYueping Zhang, Shen-Jue Chen, Cliff Chen, et al.
ACS Applied Materials & Interfaces|March 27, 2026
Revealing Intrinsic Excitonic and Interlayer Coupling in CVD-Grown TMDCs via a Bubble-Free InterfaceSudipta Majumder, Rahul Chand, Pradeepa H L, et al.
The American Journal of Pathology|January 17, 2015
The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic ratsLen Verbeke, Ricard Farre, Bert Verbinnen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 13, 2026
Investigating organic cation transporter 1 in drug interactions: New findings from in vitro and in vivo cynomolgus monkey studiesRavindranath Reddy Gilibili, Simmi Gupta, Anup Arunrao Deshpande, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2020
Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and IIISagnik Chatterjee, Sambuddho Mukherjee, L V J Sankara Sivaprasad, et al.
Journal of Medicinal Chemistry|October 14, 2025
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408Denise C Grünenfelder, Upender Velaparthi, Jayakumar S Warrier, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 23, 2017
Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition AssayRavindranath Reddy Gilibili, Sagnik Chatterjee, Pravin Bagul, et al.
Journal of Pharmaceutical Sciences|March 22, 2014
Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate dispositionTom De Bruyn, Wouter Sempels, Jan Snoeys, et al.
Developmental Medicine and Child Neurology|August 15, 2025
Neonatal hypoglycaemic brain injury, a common cause of early-childhood epilepsy in India: A prospective longitudinal study on aetiologies and outcomesChitra Gupta, Bhuvandeep Narang, S G Thenral, et al.
Brain Communications|December 11, 2023
Early-infantile developmental and epileptic encephalopathy: the aetiologies, phenotypic differences and outcomes-a prospective observational studyPooja Agarwala, Bhuvandeep Narang, Thenral S Geetha, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2022
Repression of Organic Anion Transporting Polypeptide (OATP) 1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Downregulation in Cynomolgus Monkeys Treated with Chenodeoxycholic AcidYueping Zhang, Shen-Jue Chen, Cliff Chen, et al.
ACS Applied Materials & Interfaces|March 27, 2026
Revealing Intrinsic Excitonic and Interlayer Coupling in CVD-Grown TMDCs via a Bubble-Free InterfaceSudipta Majumder, Rahul Chand, Pradeepa H L, et al.
The American Journal of Pathology|January 17, 2015
The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic ratsLen Verbeke, Ricard Farre, Bert Verbinnen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 13, 2026
Investigating organic cation transporter 1 in drug interactions: New findings from in vitro and in vivo cynomolgus monkey studiesRavindranath Reddy Gilibili, Simmi Gupta, Anup Arunrao Deshpande, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2020
Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and IIISagnik Chatterjee, Sambuddho Mukherjee, L V J Sankara Sivaprasad, et al.
Journal of Medicinal Chemistry|October 14, 2025
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408Denise C Grünenfelder, Upender Velaparthi, Jayakumar S Warrier, et al.
Pageof 3